Delivery Order SPE2DB20D7066-SPE2DB25FC3XK

Award Date 7/2/25
Potential Completion Date 7/3/25
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product, with a ceiling value of $18,670.65 and a period of performance through March 24, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. Amerisourcebergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a specialty pharmaceutical product, with a ceiling value of $4,541.10 and a period of performance through May 20, 2024. The contract does not have a set-aside designation, indicating it was an open competition....
This is a federal delivery order contract awarded by the Defense Logistics Agency Troop Support Medical, a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, with a ceiling value of $8,561.50 and a completion date of December 13, 2023. The contract is a firm fixed-price delivery order, which is part of a larger Indefinite Delivery...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a prescription medication, with a ceiling value of $1,641.14 and a period of performance through April 30, 2025. The contract is not set-aside and was awarded on April 29, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract has a firm fixed-price of $3,612.42 and a completion date of May 27, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 300ML, a pharmaceutical product, with a ceiling value of $4,091.91 and a performance period through May 8, 2025. The contract is a delivery order, with a firm fixed price pricing type. It is not set aside for any specific business category....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. The contract, valued at $2,532.72, is a firm fixed-price delivery order with an ultimate completion date of August 1, 2024. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the prime contractor for this award. This delivery order is part of a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,841.24, is for the supply of KONVOMEP 2-84 MG/ML ORAL SUSP 90ML, a medical product used in healthcare. The contract has a period of performance through February 20, 2025 and was awarded on February 19, 2025. This award is not associated with a set-aside program. The contract is part of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, with a ceiling value of $4,393.65, is for the delivery of the pharmaceutical product KONVOMEP 2-84 MG/ML ORAL SUSP 150ML. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $1,530.00, is for the delivery of KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, a pharmaceutical product. The contract has an ultimate completion date of August 7, 2024. Amerisourcebergen Drug Corp is a for-profit organization that holds several Indefinite...
  • SPE2DB20D7066
    Indefinite Delivery Contract
  • SPE2DB20D7066-SPE2DB25FC3XK
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the medication KONVOMEP 2-84 MG/ML ORAL SUSP 150ML, with a ceiling value of $1,332.16 and a period of performance through July 3, 2025.

The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

Generated 10/1/25, 10:08 AM